Johanna Inhestern - Concepedia

Author

Johanna Inhestern

Jena University Hospital ORCID

Also Known As

Inhestern, Johanna, J Inhestern, J. Inhestern, Johanna INHESTERN, Johanna Inhestern, Matti Hein

Publications

793

Citations

H-Index

Concepts

All Affiliations

Jena University Hospital Johannes Gutenberg University Mainz Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Sahlgrenska University Hospital Kobe University Hospital

About

Johanna Inhestern is an author at Jena University Hospital specializing in medicine, head and neck cancer, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	298
2	Health Sciences	2	2	237
3	Public Health	1	1	18
4	Head And Neck Surgery	1	1	23
5	Orthopaedics	1	1	23

Johanna Inhestern

Publications

763

Citations

H-Index

Page 1

	Year	Citations
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial J. Guigay, Anne Aupérin, Jérôme Fayette, The Lancet Oncology Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck Cancer	2021	214
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV Susanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, Head & Neck	2019	130
Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer Johanna Inhestern, Katrin Oertel, Viola Stemmann, PLoS ONE	2015	69
Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer Matthias Büttner, Laura D. Locati, Monica Pinto, The Journal of Clinical Endocrinology & Metabolism	2020	53
The EORTC module for quality of life in patients with thyroid cancer: phase III Susanne Singer, Susan J. Jordan, Laura D. Locati, Endocrine Related Cancer	2017	48
Role of comorbidity on outcome of head and neck cancer: a population‐based study in Thuringia, Germany Irene Göllnitz, Johanna Inhestern, Thomas Wendt, Cancer Medicine	2016	46
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1) Johanna Inhestern, Harald Schmalenberg, Andreas Dietz, Annals of Oncology Surgical OncologyPostoperative RadiotherapyMedicineSurgerySplit Tpf	2017	43
Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study Cecilie Delphin Amdal, Kristin Bjordal, Guro Lindviksmoen Astrup, International Journal of Cancer	2024	34
Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View Cecilie Delphin Amdal, Kristin Bjordal, Guro Lindviksmoen Astrup, Healthcare	2023	29
Pain on the first postoperative day after head and neck cancer surgery Johanna Inhestern, Jenny Schuerer, Christina Illge, European Archives of Oto-Rhino-Laryngology Neck Cancer SurgeryHealth SciencesPain MedicineMedicinePostoperative Pain Management	2014	23

Page 1